Universal Corporation

Universal Corporation (UVV) Market Cap

Universal Corporation has a market capitalization of .

No quote data available.

CEO: Preston Douglas Wigner

Sector: Consumer Defensive

Industry: Tobacco

IPO Date: 1988-01-05

Website: https://investor.universalcorp.com

Universal Corporation (UVV) - Company Information

Market Cap: -|Sector: Consumer Defensive

Company Profile

Universal Corporation is a global agricultural enterprise specializing in the processing and supply of leaf tobacco and a diverse range of plant-based ingredients. Its activities are organized into two primary segments: Tobacco Operations and Ingredients Operations. Within its Tobacco Operations, the company manages the entire supply chain, encompassing the procurement, financing, processing, packing, storage, and distribution of leaf tobacco to global manufacturers of consumer tobacco products. This includes sourcing and selling flue-cured, burley, and oriental tobaccos predominantly for cigarette production, as well as dark air-cured tobaccos used in cigars, cigarillos, smokeless products, and pipe tobacco. Beyond raw material supply, Universal Corporation offers a suite of value-added services such as tobacco blending, comprehensive chemical and physical testing, custom cutting for manufacturers, the production of reconstituted leaf tobacco, and just-in-time inventory management. It also supports the electronic nicotine delivery systems market and provides smoke testing. Furthermore, its analytical capabilities extend to testing for crop protection agents and tobacco components in seeds, leaves, and final products like e-cigarette liquids and vapors, alongside detailed chemical compound analysis of finished tobacco products and their mainstream smoke. The Ingredients Operations segment leverages advanced manufacturing processes to create specialized vegetable and fruit-derived ingredients, botanical extracts, and flavorings, catering to both human and pet food industries. An additional aspect of its operations involves recycling waste generated from tobacco processing. Established in 1886, the company maintains its headquarters in Richmond, Virginia.

Analyst Sentiment

50%
Hold

From 0 Active Polls

Consensus Target Matrix

Data feed parsing pending...

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$55.32
▲ +5.00% Upside
Low Target
$39.52
-25% Risk
Median Target
$53.74
2% Mid
High Target
$65.86
25% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 UNIVERSAL CORP (UVV) — Investment Overview

🧩 Business Model Overview

UNIVERSAL CORP operates as a global tobacco leaf dealer and processor. The core value chain spans (1) sourcing tobacco leaf from a geographically diversified grower base, (2) processing and conditioning leaf to meet customer specifications, (3) warehousing and logistics to manage timing and quality, and (4) selling processed leaf to cigarette and cigar manufacturers worldwide.

Customer stickiness is driven by the need for consistent leaf quality, reliable delivery windows, and qualification processes at manufacturing facilities. Cigarette makers and cigar manufacturers typically qualify suppliers for blend performance and operational continuity, which makes resourcing more than a simple commodity purchase.

💰 Revenue Streams & Monetisation Model

Revenue is primarily generated from tobacco leaf sales (including processed and conditioned leaf) to major tobacco product manufacturers. Monetisation is largely transactional, but it is underpinned by repeat purchasing and qualification continuity rather than pure one-off spot trading.

Margin drivers include (1) leaf procurement economics (pricing and purchasing discipline relative to market conditions), (2) processing and quality conversion value (upgrading leaf into salable grades and specs), and (3) logistics/handling efficiency that reduces spoilage, quality loss, and time-to-sale.

Working capital dynamics matter: the business must fund inventory and procurement cycles, so spreads and inventory turnover influence earnings quality over time, even when end-demand remains stable.

🧠 Competitive Advantages & Market Positioning

  • Cost & scale advantage in procurement: Broad sourcing relationships across growing regions improve access to suitable leaf types and reduce exposure to single-region crop variability.
  • Quality-processing capability (operational moat): Processing, conditioning, and grading know-how supports consistent performance for downstream blending requirements.
  • Customer qualification and continuity: End-manufacturers face blend-performance and supply-continuity constraints, creating a practical barrier to switching suppliers.

Competitive benchmarking: Primary comparables include Alliance One International, One Stop Systems (OTC) leaf merchant peers—and other regional tobacco leaf processors/merchants such as Dimon Inc. While many competitors participate in parts of the leaf-processing and trading value chain, UNIVERSAL CORP’s positioning emphasizes a diversified processing and merchandising footprint with a focus on delivering qualified leaf specifications to large downstream manufacturers. Rivals often vary more in (a) geographic reach, (b) processing depth across leaf types, and (c) ability to supply consistent grades through procurement cycles.

UNIVERSAL CORP’s moat is therefore less about brand and more about procurement economics, processing conversion, and supply qualification durability.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is more likely to come from mix and execution than from simple volume expansion. Key drivers include:

  • Global cigarette manufacturing demand for consistent leaf inputs: Even with category pressure in some markets, downstream manufacturers must source qualified leaf for existing production portfolios and regulatory-compliant blends.
  • Improving processing mix and grade outcomes: Better conversion of purchased leaf into higher salable grades can enhance value capture without proportionate inventory risk.
  • Geographic diversification of supply: A diversified grower and logistics footprint can stabilize sourcing economics when weather, acreage, or local policy shifts affect specific regions.
  • Long-run supplier qualification cycles: Supplier onboarding and qualification typically require time; maintaining performance standards supports multi-year relationships.

TAM expansion is best viewed through the lens of value per pound and market share within qualified supply chains rather than broad incremental penetration.

⚠ Risk Factors to Monitor

  • Commodity and cycle risk: Tobacco leaf is a crop-driven input with variability in supply, pricing, and quality. Earnings can be sensitive to procurement timing and inventory cost.
  • Credit and working-capital risk: Funding inventory and settling counterparties requires disciplined credit management and robust cash conversion.
  • Regulatory and litigation pressure on end markets: Tobacco-related regulation, excise taxes, and litigation can pressure downstream volumes, which then filters back to leaf demand.
  • Operational and quality risk: Processing performance, warehousing conditions, and spoilage management directly affect salable yield and margins.
  • Concentration risk: Revenue exposure to a limited set of large downstream manufacturers can increase negotiation leverage against suppliers.

📊 Valuation & Market View

The market typically values tobacco leaf dealers on a blend of earnings power and cycle-adjusted cash generation. Trading ranges are often influenced by:

  • Operating margins driven by procurement economics, processing yield, and logistics efficiency.
  • Working capital behavior, particularly inventory turns and funding requirements across procurement cycles.
  • Risk perception tied to commodity volatility and the credit profile of counterparties.

In practice, valuation frameworks commonly reference EV/EBITDA or earnings-based multiples, with attention to how durable margins are through different leaf-cycle conditions.

🔍 Investment Takeaway

UNIVERSAL CORP’s long-term thesis rests on a structural “how-to” moat: disciplined procurement across diversified growing regions, processing and conditioning capabilities that convert raw leaf into consistently qualified inputs, and customer continuity stemming from qualification and blend-performance needs. While the business is exposed to commodity cycles and end-market regulation, the durability of relationships and the operational conversion of leaf into saleable grades provide a credible platform for compounding value through varying supply-demand conditions.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"UVV reported Q4’26 (ended 2026-03-31) revenue of $0 and net income of -$43.3M (EPS -$1.73), representing a sharp deterioration versus Q3’26 (revenue $861.3M, net income +$33.2M). Revenue and net income quality in this quarter appear distorted by the reported zero revenue line, so trend conclusions are directionally based on profitability and cash flow rather than absolute revenue levels. QoQ, net income swung from +$33.2M to -$43.3M (down ~$76.5M). YoY comparison to 2025-03-31 is also unfavorable on profitability: net income moved from +$9.3M to -$43.3M (down ~$53.4M). Operating margin contracted materially, with operating income at -$14.1M versus +$81.0M in Q3’26. Cash flow was strong on an operating basis: operating cash flow was +$435.3M and free cash flow +$508.6M, even as dividends were paid (-$35.3M) and the company remained levered (net debt -$939.8M per the dataset sign convention). The key risk in Q4’26 is the earnings collapse alongside heavy investing/capex-level outflows. Shareholder returns are muted by price performance: market price is $52.46, with only +3.19% 1y_change. No buybacks were reported in the quarter, so total return is likely dividend- and ops-cash-flow driven rather than momentum."

Revenue Growth

Neutral

Revenue is reported as $0 in 2026-03-31 versus $861.3M in 2025-12-31, making QoQ/trajectory assessment unreliable. YoY revenue is also not comparable due to the zero reported line in the latest quarter.

Profitability

Neutral

Net income fell from +$33.2M (2025-12-31) to -$43.3M (2026-03-31), and EPS dropped to -$1.73. Operating income swung from +$80.96M to -$14.05M; margins contracted sharply.

Cash Flow Quality

Neutral

Despite the earnings loss, operating cash flow was +$435.3M and free cash flow was +$508.6M. Dividends were still paid (-$35.3M), suggesting some coverage, but the investing outflow burden was elevated.

Leverage & Balance Sheet

Caution

Equity increased to about $1.46B (2026-03-31) from ~$1.53B (2025-12-31). Debt remains substantial (total debt ~$939.8M per dataset), so resilience depends on continued cash generation.

Shareholder Returns

Neutral

Price momentum is modest: +3.19% over 1y. No buybacks reported in Q4’26; return appears more reliant on dividends/cash generation than on valuation expansion.

Analyst Sentiment & Valuation

Neutral

No price target provided. Trading metrics in the dataset for the latest quarter are not meaningful (e.g., zeros/invalids), limiting conviction on valuation versus fundamentals.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

UVV’s Q4 FY2026 results were pressured despite modest revenue growth, with an operating loss driven by noncash Shank’s goodwill impairment ($41M) and larger tobacco inventory write-downs, especially non-wrapper dark air-cured tobacco. Tobacco revenue rose in Q4 (up 3%), but segment operating income fell materially, reflecting the same inventory-related accounting impacts. Ingredients revenue edged down in Q4 and full-year ingredients profit declined, attributed to Shank’s performance plus higher fixed costs from product pipeline build. Management’s FY2027 focus is normalization and execution: they guided uncommitted inventory to remain within 10%–20%, citing early movement since March 31 and comfort from the Q4 deep inventory review. For operations, they implemented Shank’s leadership realignment to improve commercial execution and facility utilization. Key risks remain oversupply dynamics, continued tariff/inflation variability, and the time required to convert ingredients customer interest into durable revenue and margins. Sentiment is cautious but grounded in confident inventory positioning and clear execution actions.

AI IconGrowth Catalysts

  • Shank’s leadership realignment to strengthen commercial execution, improve facility utilization, and enhance financial/operational efficiency
  • Tobacco strategy emphasizing geographic diversification and correct grade/price buying under continued global oversupply
  • Ingredients platform execution to convert pipeline investments into sustained revenue and margin growth despite ongoing inflation and market headwinds

Business Development

  • CDP Supplier Engagement Assessment: moved from A- to A rating and named to CDP Supplier Engagement A list (supplier engagement/gov/emissions collaboration signal)
  • No named customers/partners/vendors disclosed in Q&A or prepared remarks; growth discussion centered on Shank’s execution and tobacco customer relationships

AI IconFinancial Highlights

  • Q4 consolidated revenue: $715M, up 2% YoY; full-year revenue: $2.9B, down slightly vs FY2025
  • Q4 operating loss: $(15)M vs operating income of $43M YoY; full-year operating income: $169M, down $64M vs FY2025
  • Net loss attributable to Universal in Q4: $(43)M vs net income of $9M YoY; full-year net income: $33M vs $95M in FY2025
  • Primary drivers: $41M noncash goodwill impairment at Shank’s (recorded in FY2026) and higher inventory write-downs in non-wrapper dark air-cured tobacco
  • Tobacco segment Q4 revenue: $632M, up 3% YoY; full-year tobacco revenue: $2.6B, down slightly
  • Tobacco segment operating income: $27M in Q4 vs $46M YoY; full-year tobacco operating income: $212M vs $240M
  • Inventory write-downs (tobacco segment): $43M in FY2026 vs $19M in FY2025 (vs $14M average across FY2021–FY2025)
  • Ingredients segment Q4 revenue: $83M vs $90M YoY; full-year ingredients revenue: $348M, up 3%
  • Ingredients segment operating income: $2M in Q4 vs $4M YoY; full-year ingredients operating income: $3M vs $12M (lower profitability tied to Shank’s and higher fixed/operating costs for product pipeline investments)

AI IconCapital Funding

  • Net debt as of March 31, 2026: $845M vs $817M at March 31, 2025 (increase tied to higher working capital usage from purchasing/selling a significantly larger tobacco crop)
  • Liquidity availability totaled over $1.2B (cash plus committed and uncommitted credit lines)
  • No share repurchase dollar amounts, debt maturities, or buyback program quantities disclosed in the transcript

AI IconStrategy & Ops

  • Noncash goodwill impairment at Shank’s: goodwill recorded ~$41M at acquisition (Oct 2021); impairment concluded after valuation analysis due to pressured revenues/profitability and lag in commercial execution vs strategy amidst market headwinds
  • Operational/accounting: inventory valued at lower of cost or net realizable value; management performed a deep dive in Q4 to determine FY2026 write-down estimates
  • Shank’s organizational realignment: leadership-level changes aimed at commercial execution, facility utilization, and financial/operational efficiency
  • FY2027 posture: maximize/optimize tobacco business, grow ingredients with disciplined execution, and strengthen overall durability

AI IconMarket Outlook

  • Uncommitted inventory guidance/range: management confident they will be within 10%–20% during fiscal 2027 (based on movement already seen since March 31, 2026; better update planned for the fiscal 2027 first-quarter call)
  • Tariff outlook: expects normalization could reduce inflationary pressure; but tariffs may remain fluid

AI IconRisks & Headwinds

  • Continued oversupply in certain tobacco styles carrying over from FY2026 oversupply transition, with large global crops expected in flue-cured and burley
  • Ingredients headwinds: continued market headwinds impacting volumes/margins and higher fixed/operating costs from growth investments/product pipeline build
  • Inventory risk: non-wrapper, dark air-cured tobacco write-downs resulted from thorough end-of-year review and current market dynamics
  • Shank’s execution risk: commercial strategy lag and conversion of customer interest into sustained revenue/margin growth can be lengthy
  • Macro/policy: inflationary pressure and tariff impacts (management emphasized navigating tariff impacts in FY2026 and expects persistence/variability)

Q&A: Analyst Interest

  • Topic: Inventory normalization and additional dark air-cured write-down risk in FY2027: Management said the disclosed inventory figure is as of March 31, 2026 and noted early buying in Brazil with observed movement in the prior two months. They guided confidence for uncommitted inventory of 10%–20% in fiscal 2027 and emphasized comfort after Q4 write-down depth and ongoing quarterly-style monitoring under accounting rules.
  • Topic: Underlying FY2027 trends in flue-cured, burley, and ingredients (outside Shank’s): Management highlighted early season conditions, large crops globally, and oversupply carryover. They stressed geographic diversification, strategic purchasing of grades/prices, and customer demand monitoring. For ingredients, they referenced persistent inflation/tariffs, but expressed encouragement in navigating headwinds and leveraging Shank’s platform investments for improved efficiency and profitability.
  • Topic: Capital allocation priorities and how to balance dividend with ingredients investment: Management reaffirmed four-pillar strategy (invest in tobacco growth, increase dividend, explore plant-based ingredients growth, return excess via repurchases). They cited dividend payout ratio on reported net income over 100% this year, but adjusted basis below 75% over five years, indicating dividend funding support. For ingredients, they emphasized organic investment now entering return-realization phase post-2021 Shank’s expansion, not near-term new acquisitions.

Sentiment: CAUTIOUS

Note: This summary was synthesized by AI from the UVV Q4 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — Universal Corporation (UVV) Financial Profile